Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease

Patients with diabetes and chronic kidney disease (CKD) are at particularly high risk for cardiovascular disease (CVD). This post hoc analysis from the PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive) investigated the relationship between CKD and incident CVD in a populati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Schneider, Christian A., Ferrannini, Ele, DeFronzo, Ralph, Schernthaner, Guntram, Yates, John, Erdmann, Erland
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2008
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2391042/
https://ncbi.nlm.nih.gov/pubmed/18057215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2007060678
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki